about
Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain controlGABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.Validating γ oscillations and delayed auditory responses as translational biomarkers of autismPyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia.MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autismParvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits.mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autismMeasuring the maturity of the fast-spiking interneuron transcriptional program in autism, schizophrenia, and bipolar disorderSystems biology and gene networks in neurodevelopmental and neurodegenerative disorders.The Genetics-Driven Revival in Neuropsychiatric Drug Development.Chromosome conformation elucidates regulatory relationships in developing human brain.Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophreniaConvergence of circuit dysfunction in ASD: a common bridge between diverse genetic and environmental risk factors and common clinical electrophysiology.The road to precision psychiatry: translating genetics into disease mechanisms.Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism.The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability.NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophreniaNMDA antagonist MK801 recreates auditory electrophysiology disruption present in autism and other neurodevelopmental disorders.A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice.In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia.Ketamine modulates theta and gamma oscillations.Cannabis-induced psychosis associated with high potency "wax dabs".N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.Nicotine normalizes event related potentials in COMT-Val-tg mice and increases gamma and theta spectral density.Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap.Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorderComprehensive functional genomic resource and integrative model for the human brainMechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic InterventionsProfiling allele-specific gene expression in brains from individuals with autism spectrum disorder reveals preferential minor allele usage
P50
Q24568208-10847C40-28E2-446E-93DF-791615244263Q24625065-7AB67317-BBE7-45B4-B45A-6FFC04AE9E98Q30372103-3601F1AC-23C0-4AAC-ACEF-32A0E649F355Q30388341-986585BF-FB83-479F-80D7-F89D7A138C1EQ30468313-8CDB48C2-69FA-4946-B4D8-09FA611213CFQ30475452-22AE7ECF-38FD-4762-99ED-BE1E9A3CAE47Q30578270-CC7092B9-02C2-4294-B789-D625CB181286Q34053492-8B8D695E-C6D3-4F65-9895-0DA1521D1B49Q34398794-05843AF9-3C98-4507-B019-BABDDA6B6C5AQ36424672-558ABC6F-98CA-4709-81E4-54C3E7DE828CQ37666098-A0FA6029-472F-4869-AE47-21F4D66C75EBQ37712138-A8CDE671-BC60-4002-9C47-215880E18B6BQ37846896-7280B12F-0700-472F-85D3-AF2D857D2965Q38299791-2154BC08-D941-4A49-B6ED-A0A885134D4CQ38992286-980D2D26-E819-4CB6-A92F-A1658A6FB0AAQ39129795-91C653D4-ACC0-4596-9A9B-5AA84C1690EAQ40145512-1D9264B6-DCE8-4319-BBB0-2CDC60E0F8F6Q41818221-9378D416-C987-4AAE-8C62-C66C4D81627FQ42242034-7BCE854F-3DD9-4A04-AF43-DA70DE3CE21DQ42580878-66127A9A-8CF9-46A7-8294-7A2B8DD79D1CQ43084552-934E8CEB-B4F1-4950-9398-E12CA88E5DB0Q45937104-44F841DB-3C06-427D-AC7F-9756D4EC6EF3Q46081550-190021C3-DA68-4A3A-BE5C-5DB51B98A042Q46241563-2031118F-5370-4086-9641-6C11EC9D4378Q48671672-53995E04-9146-45BD-B9D7-7B455B124425Q50034912-4C5E2B3B-847A-4758-8DA9-047686BA6A7BQ62749448-94F12F4B-5676-4496-A3FF-811D76D3F5A5Q90462411-B7CC1DF7-530A-4132-95C7-7BEA9D201E08Q90753130-821FE7AE-2E48-458B-B4E4-A2C4217A35EAQ92914399-0A241694-BE14-43B5-B667-8ED8E9E99B34
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael J. Gandal
@ast
Michael J. Gandal
@en
Michael J. Gandal
@es
Michael J. Gandal
@nl
Michael J. Gandal
@sl
type
label
Michael J. Gandal
@ast
Michael J. Gandal
@en
Michael J. Gandal
@es
Michael J. Gandal
@nl
Michael J. Gandal
@sl
prefLabel
Michael J. Gandal
@ast
Michael J. Gandal
@en
Michael J. Gandal
@es
Michael J. Gandal
@nl
Michael J. Gandal
@sl
P1053
J-8787-2013
P106
P1153
25222786000
P21
P31
P3829
P496
0000-0001-5800-5128